Search

Your search keyword '"Cimadamore, Alessia"' showing total 826 results
Start Over Author "Cimadamore, Alessia"
826 results on '"Cimadamore, Alessia"'

151. The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis

Author

Stangl-Kremser, Judith, primary, Muto, Gianluca, additional, Grosso, Antonio Andrea, additional, Briganti, Alberto, additional, Comperat, Eva, additional, Di Maida, Fabrizio, additional, Montironi, Rodolfo, additional, Remzi, Mesut, additional, Pradere, Benjamin, additional, Soria, Francesco, additional, Albisinni, Simone, additional, Roupret, Morgan, additional, Shariat, Shahrokh Francois, additional, Minervini, Andrea, additional, Teoh, Jeremy Yuen-Chun, additional, Moschini, Marco, additional, Cimadamore, Alessia, additional, and Mari, Andrea, additional

Published
2022
Full Text
View/download PDF

153. MP27-02 NOT ALL ADVERSE PATHOLOGY FEATURES ARE EQUAL: IDENTIFYING OPTIMAL CANDIDATES FOR ADJUVANT RADIOTHERAPY AMONG PATIENTS WITH ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY

Author

Mazzone, Elio, primary, Gandaglia, Giorgio, additional, Stabile, Armando, additional, Fossati, Nicola, additional, Gallina, Andrea, additional, Zaffuto, Emanuele, additional, Picozzi, Marta, additional, Barletta, Francesco, additional, Scuderi, Simone, additional, Leni, Riccardo, additional, Nocera, Luigi, additional, Sorce, Gabriele, additional, Pellegrino, Francesco, additional, Rosiello, Giuseppe, additional, Capitanio, Umberto, additional, Larcher, Alessandro, additional, Lucianò, Roberta, additional, Cimadamore, Alessia, additional, Dehò, Federico, additional, Montironi, Rodolfo, additional, Karakiewicz, Pierre I., additional, Shariat, Shahrokh F., additional, Montorsi, Francesco, additional, and Briganti, Alberto, additional

Published
2022
Full Text
View/download PDF

154. PD60-03 THE IMPACT OF HISTOLOGICAL VARIANTS ON THE PERFORMANCE CHARACTERISTICS OF 68GA-PSMA PET/CT IN THE PRIMARY AND RECURRENT SETTING

Author

Scuderi, Simone, primary, Mazzone, Elio, additional, Gandaglia, Giorgio, additional, Lucianò, Roberta, additional, Tenace, Nazario Pio, additional, Cimadamore, Alessia, additional, Necchi, Andrea, additional, Raggi, Daniele, additional, Marandino, Laura, additional, Leni, Riccardo, additional, Robesti, Daniele, additional, Toneatto, Lorenzo, additional, Cannoletta, Donato, additional, Quarta, Leonardo, additional, De Angelis, Mario, additional, Pellegrino, Francesco, additional, Sorce, Gabriele, additional, Barletta, Francesco, additional, Nocera, Luigi, additional, Rosiello, Giuseppe, additional, Stabile, Armando, additional, Montorsi, Francesco, additional, and Briganti, Alberto, additional

Published
2022
Full Text
View/download PDF

155. ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation

Author

Lorenzoni, Marco, primary, De Felice, Dario, additional, Beccaceci, Giulia, additional, Di Donato, Giorgia, additional, Foletto, Veronica, additional, Genovesi, Sacha, additional, Bertossi, Arianna, additional, Cambuli, Francesco, additional, Lorenzin, Francesca, additional, Savino, Aurora, additional, Avalle, Lidia, additional, Cimadamore, Alessia, additional, Montironi, Rodolfo, additional, Weber, Veronica, additional, Carbone, Francesco Giuseppe, additional, Barbareschi, Mattia, additional, Demichelis, Francesca, additional, Romanel, Alessandro, additional, Poli, Valeria, additional, Del Sal, Giannino, additional, Kruithof-de Julio, Marianna, additional, Gaspari, Marco, additional, Alaimo, Alessandro, additional, and Lunardi, Andrea, additional

Published
2022
Full Text
View/download PDF

156. MP53-07 HISTOLOGICAL VARIANTS OF PROSTATE CANCER ARE UNDER-REPORTED IN PROSTATE BIOPSIES ASSESSED OUTSIDE TERTIARY REFERRAL CENTERS. A PLEA FOR BIOPSY REVIEW FOR OPTIMAL PATIENT MANAGEMENT

Author

Scuderi, Simone, primary, Pellegrino, Francesco, additional, Lucianò, Roberta, additional, Tenace, Nazario, additional, Paparesta, Francesca, additional, Pepi, Laura, additional, Quarta, Leonardo, additional, Toneatto, Lorenzo, additional, Mazzone, Elio, additional, Barletta, Francesco, additional, Mario, De Angelis, additional, Robesti, Daniele, additional, Cannoletta, Donato, additional, Pellegrino, Antony, additional, Cucchiara, Vito, additional, Leni, Riccardo, additional, Gandaglia, Giorgio, additional, Stabile, Armando, additional, Cimadamore, Alessia, additional, Montironi, Rodolfo, additional, Montorsi, Francesco, additional, and Briganti, Alberto, additional

Published
2022
Full Text
View/download PDF

158. Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems

Author

Marletta, S, Fusco, N, Munari, E, Luchini, C, Cimadamore, A, Brunelli, M, Querzoli, G, Martini, M, Vigliar, E, Colombari, R, Girolami, I, Pagni, F, Eccher, A, Marletta, Stefano, Fusco, Nicola, Munari, Enrico, Luchini, Claudio, Cimadamore, Alessia, Brunelli, Matteo, Querzoli, Giulia, Martini, Maurizio, Vigliar, Elena, Colombari, Romano, Girolami, Ilaria, Pagni, Fabio, Eccher, Albino, Marletta, S, Fusco, N, Munari, E, Luchini, C, Cimadamore, A, Brunelli, M, Querzoli, G, Martini, M, Vigliar, E, Colombari, R, Girolami, I, Pagni, F, Eccher, A, Marletta, Stefano, Fusco, Nicola, Munari, Enrico, Luchini, Claudio, Cimadamore, Alessia, Brunelli, Matteo, Querzoli, Giulia, Martini, Maurizio, Vigliar, Elena, Colombari, Romano, Girolami, Ilaria, Pagni, Fabio, and Eccher, Albino

Abstract

Background. Innovative drugs targeting the PD1/PD-L1 axis have opened promising sce-narios in modern cancer therapy. Plenty of assays and scoring systems have been developed for the evaluation of PD-L1 immunohistochemical expression, so far considered the most reliable therapeutic predictive marker. Methods. By gathering the opinion of acknowledged experts in dedicated fields of pathology, we sought to update the currently available evidence on PD-L1 assessment in various types of tumors. Results. Robust data were progressively collected for several anatomic districts and leading international agencies to approve specific protocols: among these, TPS with 22C3, SP142 and SP263 clones in lung cancer; IC with SP142 antibody in breast, lung and urothelial tumors; and CPS with 22C3/SP263 assays in head and neck and urothelial carcinomas. On the other hand, for other malignancies, such as gastroenteric neoplasms, immunotherapy has been only recently introduced, often for particular histotypes, so specific guidelines are still lacking. Conclu-sions. PD-L1 immunohistochemical scoring is currently the basis for allowing many cancer patients to receive properly targeted therapies. While protocols supported by proven data are already available for many tumors, dedicated studies and clinical trials focusing on harmonization of the topic in other still only partially explored fields are surely yet advisable.

Published
2022

159. Digital real-time microscopy of ex-vivo tissues: A novel strategy to control surgical accuracy.

Author

Sighinolfi, Maria Chiara, Cimadamore, Alessia, Cassani, Alessandra, Assumma, Simone, Sarchi, Luca, Filippi, Beatrice, Turri, Filippo, Reggiani Bonetti, Luca, Maiorana, Antonino, Eissa, Ahmed, Micali, Salvatore, Montironi, Rodolfo, and Rocco, Bernardo

Subjects
*RETROPUBIC prostatectomy, *SURGICAL margin, *DIGITAL images, *RADICAL prostatectomy, *BLADDER cancer, *OPERATIVE surgery, *TISSUES, *PROSTATE cancer
Abstract

Introduction: Ex-vivo FCM is a novel digital optical technique that provides images of fresh tissues in a real-time fashion with magnification to subcellular details of a flattened unprocessed sample. Digital images are hematoxylin-eosin-like and can be shared and interpreted remotely. In urology, FCM has been successfully applied for prostate tissue interpretation, either during biopsy and radical prostatectomy. Possible applications of FCM may reflect those of frozen section analysis and can be extended to all fields in which the intra-operative microscopical control is advisable. Materials and methods: This is an investigative prospective case series that aims to explore FCM feasibility in novel surgical settings and provide a depiction of FCM digital images in those fields. The definite purpose is to check the accuracy of surgical specimen during the following interventions: (a) trans-urethral resection of bladder tumors, to confirm the presence of muscular layer; (b) biopsy of a retroperitoneal mass, to check for the location and quality of cores; (c) training in robotic radical prostatectomy, to control surgical margins after a nerve sparing performed by a trainee. To this aim, we collected FCM images during seven surgical procedures. FCM findings were compared to those from the final histopathological analysis and the agreement was assessed. Results: In all cases, FCM digital images were obtained in the OR. FCM was able to confirm the presence of muscular layer in TURB specimen, the presence of lymphomatous tissue, surgical margins at prostate specimen. FCM intra-operative interpretation was consistent with final histopathology in all cases. Conclusions: Ex vivo FCM may represent a novel approach to control the quality of specimens, likely to tailor surgical strategy in a real-time fashion. Moreover, digitalization represents a step toward the implementation of telepathology in clinical practice. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

160. Myoid gonadal stromal tumours are characterised by recurrent chromosome‐level copy number gains: molecular assessment of a multi‐institutional series.

Author

Collins, Katrina, Sholl, Lynette M., Siegmund, Stephanie, Dickson, Brendan C., Colecchia, Maurizio, Michalová, Květoslava, Hwang, Michael, Ulbright, Thomas M., Kao, Chia‐Sui, van Leenders, Geert J.L.H., Mehta, Vikas, Trpkov, Kiril, Yilmaz, Asli, Cimadamore, Alessia, Matoso, Andres, Epstein, Jonathan I., Maclean, Fiona, Comperat, Eva, Anderson, William J., and Fletcher, Christopher D.M.

Subjects
DNA copy number variations, GENE fusion, TUMORS, RNA sequencing, PROTEIN expression, MYOFIBROBLASTS, MITOSIS
Abstract

Myoid gonadal stromal tumours (MGST) represent a rare type of testicular sex cord‐stromal tumour that has recently been recognised as a distinct entity by the World Health Organization (WHO) classification of genitourinary tumours. MGSTs affect adult men and have been reported to behave in an indolent fashion. Histologically, MGSTs are pure spindle cell neoplasms that coexpress SMA and S100 protein. Given that the molecular features of these neoplasms remain largely undescribed, we evaluated a multi‐institutional series of MGSTs using DNA and RNA sequencing. This study included 12 tumours from 12 patients aged 28 to 57 years. Tumour sizes ranged from 0.6 to 4.3 cm. Aggressive histologic features, such as vascular invasion, necrosis, invasive growth, and atypical mitoses were invariably absent. Mitotic activity was low, with a median of less than 1 mitosis per 10 high power fields (HPF; maximum: 3 mitoses per 10 HPF). Molecular analyses did not identify recurrent mutations or gene fusions. All cases with interpretable copy number variant data (9/10 cases sequenced successfully) demonstrated a consistent pattern of chromosome arm‐level and whole‐chromosome‐level copy number gains indicative of ploidy shifts, with recurrent gains involving chromosomes 3, 6, 7, 8, 9, 11, 12, 14q, 15q, 17, 18q, 20, and 21q. Similar findings have also been recognised in pure spindle cell and spindle‐cell predominant sex cord‐stromal tumours without S100 protein expression. MGSTs are characterised by ploidy shifts and may be part of a larger spectrum of spindle cell‐predominant sex cord‐stromal tumours, including cases without S100 protein expression. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

161. Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report.

Author

Atkins, Michael B., primary, Jegede, Opeyemi, additional, Haas, Naomi B., additional, McDermott, David F., additional, Bilen, Mehmet Asim, additional, Stein, Mark N., additional, Sosman, Jeffrey Alan, additional, Alter, Robert S., additional, Plimack, Elizabeth R., additional, Ornstein, Moshe Chaim, additional, Hurwitz, Michael E., additional, Peace, David J., additional, Signoretti, Sabina, additional, Denize, Thomas, additional, Cimadamore, Alessia, additional, Braun, David A., additional, Wu, Catherine J., additional, Einstein, David Johnson, additional, Catalano, Paul J., additional, and Hammers, Hans J., additional

Published
2022
Full Text
View/download PDF

162. PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?

Author

Marchetti, Andrea, primary, Rosellini, Matteo, additional, Nuvola, Giacomo, additional, Tassinari, Elisa, additional, Mollica, Veronica, additional, Rizzo, Alessandro, additional, Santoni, Matteo, additional, Cimadamore, Alessia, additional, Farolfi, Andrea, additional, Montironi, Rodolfo, additional, Fanti, Stefano, additional, and Massari, Francesco, additional

Published
2022
Full Text
View/download PDF

164. A gender-related dichotomy in bladder cancer

Author

Cimadamore, Alessia, Teoh, Jeremy Y, DI Trapani, Ettore, Krajewski, Wojciech, Tan, Wei Shen, Mori, Keiichiro, Del Giudice, Francesco, Carrion, Diego M, and Moschini, Marco

Subjects
Carcinoma, Transitional Cell, Rare Diseases, Urinary Bladder Neoplasms, Nephrology, Risk Factors, Urology, Humans
Published
2022

165. sj-docx-1-urj-10.1177_03915603221122731 – Supplemental material for Digital real-time microscopy of ex-vivo tissues: A novel strategy to control surgical accuracy

Author

Sighinolfi, Maria Chiara, Cimadamore, Alessia, Cassani, Alessandra, Assumma, Simone, Sarchi, Luca, Filippi, Beatrice, Turri, Filippo, Reggiani Bonetti, Luca, Maiorana, Antonino, Eissa, Ahmed, Micali, Salvatore, Montironi, Rodolfo, and Rocco, Bernardo

Subjects
Medicine
Abstract

Supplemental material, sj-docx-1-urj-10.1177_03915603221122731 for Digital real-time microscopy of ex-vivo tissues: A novel strategy to control surgical accuracy by Maria Chiara Sighinolfi, Alessia Cimadamore, Alessandra Cassani, Simone Assumma, Luca Sarchi, Beatrice Filippi, Filippo Turri, Luca Reggiani Bonetti, Antonino Maiorana, Ahmed Eissa, Salvatore Micali, Rodolfo Montironi and Bernardo Rocco in Urologia Journal

Published
2022
Full Text
View/download PDF

166. ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3�� dependent Nkx3.1 degradation

Author

Lorenzoni, Marco, De Felice, Dario, Beccaceci, Giulia, Di Donato, Giorgia, Foletto, Veronica, Genovesi, Sacha, Bertossi, Arianna, Cambuli, Francesco, Lorenzin, Francesca, Savino, Aurora, Avalle, Lidia, Cimadamore, Alessia, Montironi, Rodolfo, Weber, Veronica, Carbone, Francesco Giuseppe, Barbareschi, Mattia, Demichelis, Francesca, Romanel, Alessandro, Poli, Valeria, Del Sal, Giannino, Kruithof-de Julio, Marianna, Gaspari, Marco, Alaimo, Alessandro, and Lunardi, Andrea

Subjects
610 Medicine & health
Abstract

21q22.2-3 deletion is the most common copy number alteration in prostate cancer (PCa). The genomic rearrangement results in the androgen-dependent de novo expression of ETS-related gene (ERG) in prostate cancer cells, a condition promoting tumor progression to advanced stages of the disease. Interestingly, ERG expression characterizes 5-30% of tumor precursor lesions - High Grade Prostatic Intraepithelial Neoplasia (HGPIN) - where its role remains unclear. Here, by combining organoids technology with Click-chemistry coupled Mass Spectrometry, we demonstrate a prominent role of ERG in remodeling the protein secretome of prostate progenitors. Functionally, by lowering autocrine Wnt-4 signaling, ERG represses canonical Wnt pathway in prostate progenitors, and, in turn, promotes the accumulation of DNA double strand breaks via Gsk3��-dependent degradation of the tumor suppressor Nkx3.1. On the other hand, by shaping extracellular paracrine signals, ERG strengthens the pro-oxidative transcriptional signature of inflammatory macrophages, which we demonstrate to infiltrate pre-malignant ERG positive prostate lesions. These findings highlight previously unrecognized functions of ERG in undermining adult prostate progenitor niche through cell autonomous and non-autonomous mechanisms. Overall, by supporting the survival and proliferation of prostate progenitors in the absence of growth stimuli and promoting the accumulation of DNA damage through destabilization of Nkx3.1, ERG could orchestrate the prelude to neoplastic transformation.

Published
2022
Full Text
View/download PDF

169. The most effective but largely ignored target for prostate cancer early detection and intervention

Author

Man, Yan-gao, primary, Mannion, Ciaran, additional, Jewett, Anahid, additional, Hsiao, Yi-Hsuan, additional, Liu, Aijun, additional, Semczuk, Andrzej, additional, Zarogoulidis, Paul, additional, Gapeev, Andrei B., additional, Cimadamore, Alessia, additional, Lee, Peng, additional, Lopez-Beltran, Antonio, additional, Montironi, Rodolfo, additional, Massari, Francesco, additional, Lu, Xin, additional, and Cheng, Liang, additional

Published
2022
Full Text
View/download PDF

171. From Undergraduate Medical School Student to Visible Pathologist

Author

Montironi, Rodolfo, Cimadamore, Alessia, and Scarpelli, Marina

Subjects
Health
Abstract

To the Editor.--It is with great interest that we have read the recent contribution to the Archives of Pathology & Laboratory Medicine by Harrold et al (1) entitled Emerging from [...]

Published
2020

172. Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial

Author

Denize, Thomas, primary, Farah, Subrina, additional, Cimadamore, Alessia, additional, Flaifel, Abdallah, additional, Walton, Emily, additional, Sticco-Ivins, Maura A, additional, Labaki, Chris, additional, Braun, David A, additional, Sun, Maxine, additional, Wang, Evelyn, additional, Xie, Wanling, additional, Choueiri, Toni K, additional, and Signoretti, Sabina, additional

Published
2021
Full Text
View/download PDF

175. Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique

Author

Rocco, Bernardo, primary, Sarchi, Luca, additional, Assumma, Simone, additional, Cimadamore, Alessia, additional, Montironi, Rodolfo, additional, Reggiani Bonetti, Luca, additional, Turri, Filippo, additional, De Carne, Cosimo, additional, Puliatti, Stefano, additional, Maiorana, Antonino, additional, Pellacani, Giovanni, additional, Micali, Salvatore, additional, Bianchi, Giampaolo, additional, and Sighinolfi, Maria Chiara, additional

Published
2021
Full Text
View/download PDF

176. Correlation between High PD-L1 and EMT/Invasive Genes Expression and Reduced Recurrence-Free Survival in Blood-Circulating Tumor Cells from Patients with Non-Muscle-Invasive Bladder Cancer

Author

Morelli, Maria Beatrice, primary, Amantini, Consuelo, additional, Rossi de Vermandois, Jacopo Adolfo, additional, Gubbiotti, Marilena, additional, Giannantoni, Antonella, additional, Mearini, Ettore, additional, Maggi, Federica, additional, Nabissi, Massimo, additional, Marinelli, Oliviero, additional, Santoni, Matteo, additional, Cimadamore, Alessia, additional, Montironi, Rodolfo, additional, and Santoni, Giorgio, additional

Published
2021
Full Text
View/download PDF

179. Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182–91: Image Analysis, Nuclear Abnormality Index, and Pattern Recognition Analysis

Author

Cimadamore, Alessia, Lopez-Beltran, Antonio, Scarpelli, Marina, Cheng, Liang, and Montironi, Rodolfo

Published
2021
Full Text
View/download PDF

182. BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma

Author

Murrone, Albero, primary, Cantini, Luca, additional, Pecci, Federica, additional, Cognigni, Valeria, additional, Copparoni, Cecilia, additional, Rinaldi, Silvia, additional, Fiordoliva, Ilaria, additional, Monaco, Federica, additional, Rubini, Corrado, additional, Barbisan, Francesca, additional, Cimadamore, Alessia, additional, Giampieri, Riccardo, additional, Bianchi, Francesca, additional, Tomasetti, Marco, additional, Amati, Monica, additional, Santarelli, Lory, additional, and Berardi, Rossana, additional

Published
2021
Full Text
View/download PDF

184. Reply to Eoin Dinneen, Jon Oxley, and Greg Shaw’s Letter to the Editor re: Bernardo Rocco, Luca Sarchi, Simone Assumma, et al. Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.021

Author

Rocco, Bernardo, primary, Cimadamore, Alessia, additional, Sighinolfi, Maria Chiara, additional, Assumma, Simone, additional, and Montironi, Rodolfo, additional

Published
2021
Full Text
View/download PDF

185. Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis

Author

Santoni, Matteo, Massari, Francesco, Rizzo, Alessandro, Mollica, Veronica, Cimadamore, Alessia, Montironi, Rodolfo, and Battelli, Nicola

Abstract

The treatment of castration-sensitive prostate cancer (CSPC) has been revolutionized by the advent of apalutamide and enzalutamide in this setting; however, a direct comparison between these agents is still missing. In the current paper, we performed both Number Needed to Treat (NNT) and Number Needed to Harm (NNH) analyses aimed to compare clinical outcomes in CSPC patients treated with apalutamide or enzalutamide; data from 3323 CSPC patients enrolled in the ARCHES, ENZAMET and TITAN phase III studies were included. According to our results, apalutamide showed better results in terms of overall survival (OS) and safety in patients with CSPC, while better outcomes were observed with enzalutamide in the low-volume subgroup.

Published
2023
Full Text
View/download PDF

187. Whole Slide Imaging of Large Format Histology in Prostate Pathology: Potential for Information Fusion

Author

Montironi, Rodolfo, Cimadamore, Alessia, Massari, Francesco, Montironi, Maria Alessandra, Lopez-Beltran, Antonio, Cheng, Liang, Montorsi, Francesco, and Scarpelli, Marina

Subjects
Diagnostic imaging -- Methods, Pathological histology -- Methods, Prostate cancer -- Diagnosis, Health
Abstract

To the Editor.--We read with considerable interest the contribution written by Alton Brad Farris, MD, and colleagues (1) in the April 2017 issue of the Archives of Pathology & Laboratory [...]

Published
2017
Full Text
View/download PDF

188. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.

Author

Al-Obaidy, Khaleel I., Saleeb, Rola M., Trpkov, Kiril, Williamson, Sean R., Sangoi, Ankur R., Nassiri, Mehdi, Hes, Ondrej, Montironi, Rodolfo, Cimadamore, Alessia, Acosta, Andres M., Alruwaii, Zainab I., Alkashash, Ahmad, Hassan, Oudai, Gupta, Nilesh, Osunkoya, Adeboye O., Sen, Joyashree D., Baldrige, Lee Ann, Sakr, Wael A., Idrees, Muhammad T., and Eble, John N.

Published
2022
Full Text
View/download PDF

192. The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What’s the Story Morning Glory?

Author

Marchetti, Andrea, primary, Rosellini, Matteo, additional, Mollica, Veronica, additional, Rizzo, Alessandro, additional, Tassinari, Elisa, additional, Nuvola, Giacomo, additional, Cimadamore, Alessia, additional, Santoni, Matteo, additional, Fiorentino, Michelangelo, additional, Montironi, Rodolfo, additional, and Massari, Francesco, additional

Published
2021
Full Text
View/download PDF

199. An update on immunotherapy in uro-oncology

Author

Cimadamore, Alessia, primary, Rizzo, Alessandro, additional, Mollica, Veronica, additional, Massari, Francesco, additional, Lopez-Beltran, Antonio, additional, Scarpelli, Marina, additional, Cheng, Liang, additional, Santoni, Matteo, additional, and Montironi, Rodolfo, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results